B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MUSCARINIC

MOLECULAR TARGET

Muscarinic acetylcholine receptor M5 (human)

UniProt: P0891232 compounds

MUSCARINIC (Muscarinic acetylcholine receptor M5 (human)) is targeted by 32 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MUSCARINIC

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hyoscyamine3.4731
2Quetiapine Fumarate2.4811
3Amoxapine2.4811
4Nortriptyline2.4811
5Mianserin2.4010
6Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent2.4010
7Astemizole Antihistamine drug now withdrawn from2.4010
8Cyclizine2.4010
9Cyproheptadine2.4010
10Dimenhydrinate2.4010
11Maprotiline2.4010
12Promethazine2.4010
13Sertraline2.208
14Cinnarizine2.208
15Econazole2.208
16Flunarizine Flunarizine is2.208
17Miconazole2.208
18Clotrimazole1.956
19pentamidine1.956
20Arecoline1.795
21N-Methylscopolamine1.795
22Scopolamine1.795
23Oxymetazoline1.614
24Ethylestrenol1.102
25Irinotecan1.102
26Muscarine1.102
27Pilocarpine1.102
28Danazol0.691
29Dimethindene0.691
30Ipratropium0.691
31Loxapine0.691
32Metergoline0.691

About MUSCARINIC as a Drug Target

MUSCARINIC (Muscarinic acetylcholine receptor M5 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 32 compounds with documented MUSCARINIC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MUSCARINIC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.